Group items tagged

Ambulance drivers play an important role in the quick transportation of patients with urgent needs. Being an ambulance driver requires a lot of time and effort. With MedCab, you can earn more as an ambulance driver, get more bookings and reach more locations. MedCab is an online platform that caters to urgent medical needs and emergency ambulance service requirements. MedCab is available for bookings in all the major Indian cities, such as Delhi, Gurgaon, Bangalore, Lucknow and Chennai. For ambulance drivers, MedCab serves as an online urgent ambulance booking app. How to Get More Ambulance Bookings? You can increase your daily ambulance bookings with MedCab. MedCab helps ambulance drivers get more customer bookings and earn more. Our app will connect you to people around your location who require urgent ambulance services. To get more bookings using MedCab, you need to follow these simple steps - * Download our app from Google Play store. * Sign up with your personal details and ambulance details. * After verification from the MedCab team, you are a certified Partner of MedCab. * Start accepting bookings through the app and earn more money! The ambulance driver registration process has been made simple with the MedCab app. So, increase your daily bookings by downloading the app. What are the Benefits of Signing up with MedCab? There are many benefits of signing up as a MedCab Partner, such as - Available all across India - MedCab is a popular ambulance booking service across all major cities in India. It offers convenient and easy ambulance booking services all across India. More ambulance bookings - With MedCab, you have a higher chance of getting more urgent ambulance bookings in your location. MedCab is powered by GPS technology that uses your mobile phone's location to connect you with people who need fast and quick ambulance services. Option of getting tips for each booking - The more bookings you take through the

Too many carbs, not fats, may be the culprit in raising risk of premature death, according to a study published online Aug. 29 in the The Lancet to coincide with the European Society of Cardiology Congress 2017, held from Aug. 26 to 30 in Barcelona, Spain. Mahshid Dehghan, Ph.D., an investigator with the Population Health Research Institute at McMaster University in Hamilton, Canada, and colleagues tracked the diet and health of 135,335 people, aged 35 to 70, from 18 countries around the world, to gain a global perspective on the health effects of diet. Participants provided detailed information on their social and economic status, lifestyle, medical history, and current health. They also completed a questionnaire on their regular diet, which researchers used to calculate their average daily calories from fats, carbohydrates, and proteins. The research team then tracked the participants' health for about seven years on average, with follow-up visits at least every three years. The investigators found that high-carbohydrate diets are common, with more than half of the people deriving 70 percent of their daily calories from carbs. People with a high fat intake -- about 35 percent of their daily diet -- had a 23 percent lower risk of early death and 18 percent lower risk of stroke compared to people who ate less fat. The researchers also noted that a very low intake of saturated fats (below 3 percent of daily diet) was associated with a higher risk of death in the study, compared to diets containing up to 13 percent daily. At the same time, high-carb diets -- containing an average 77 percent carbohydrates -- were associated with a 28 percent increased risk of death versus low-carb diets. "The study showed that contrary to popular belief, increased consumption of dietary fats is associated with a lower risk of death," Dehghan told HealthDay. "We found no evidence that below 10 percent of energy by saturated fat is beneficial, and going below 7 percent may even be har

eMedEvents is recognized as a Winner of eHealthcare Leadership Awards at a special presentation on November 11, 2015 at the 19th Annual Healthcare Internet Conference in Orlando, Florida. eMedEvents won the Best Overall Internet Site-Silver award under physician focused category for an outstanding website. Judges reviewed eMedEvents based on a proprietary multi-point standard of Internet excellence. The Best Overall Internet Site category had to meet more than 40 factors. Ms. Priya Korrapati, CEO of eMedEvents, has said, "We passionately believe in building a technology empowered platform that helps healthcare professionals and provide tools to find medical conferences that fits each physician's unique CME needs" on winning the prestigious award. The eHealthcare Leadership Awards 2015 has received tremendous response with over 1000 entries competing in 15 different categories and diverse healthcare backgrounds. The awards highlight the role played by the Internet in helping healthcare organizations achieve their objectives. The awards also celebrate the hard work that lies underneath each of the winning websites and digital communications initiatives. About eMedEvents eMedEvents is a leading website with most comprehensive database of medical conferences for physicians to discover medical conferences that fit with their unique needs such as CME credits, Location preferences and Board reviews. With over 6000 medical conferences 2015 to choose from, the website is a perfect location to find any medical conference in multiple medical specialties across the globe. About eHealthcare Leadership awards The Healthcare Internet Conference is a popular event that brings together the leaders from various disciplines of the healthcare industry to learn, collaborate and celebrate best practices. The conference aims at helping the healthcare leaders with the ever growing challenges of the online world through collaboration with leading marketers, and other web based service

For patients with stage 4 or 5 chronic kidney disease and hepatitis C virus (HCV) infection, 12 weeks of treatment with glecaprevir and pibrentasvir results in a high rate of sustained virologic response, according to a study published online Oct. 11 in the New England Journal of Medicine. Edward Gane, M.D., from Auckland City Hospital in New Zealand, and colleagues conducted a multicenter trial to examine the efficacy and safety of combination treatment with the NS3/4A protease inhibitor glecaprevir and the NS5A inhibitor pibrentasvir for 12 weeks in adults with HCV infection and compensated liver disease with severe renal impairment, dependence on dialysis, or both. Participants had stage 4 or 5 chronic kidney disease. One hundred four patients were enrolled in the trial. The researchers found that the sustained virologic response rate was 98 percent. During treatment, none of the patients had virologic failure, and none had a virologic relapse after the end of treatment. Pruritus, fatigue, and nausea were reported in at least 10 percent of the patients. Twenty-four percent of the patients reported serious adverse events. Because of adverse events, four patients discontinued the trial treatment prematurely; three of these had sustained virologic response

Transcatheter Cardiovascular Therapeutics (TCT) is organized by CardioVascular Research Foundation (CRF) and would be held during Oct 29 - Nov 2, 2017 at Colorado Convention Center, Denver, Colorado, United States of America. The target audience for this medical event for interventional cardiologists, radiologists, clinical cardiologists, scientists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technicians, and other healthcare professionals with a special interest in the field of interventional and vascular medicine. Activity Goals : The overall goal of this activity is to improve the competence and performance of our target audience by delivering cutting-edge educational content that showcases the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation will translate into improved patient care. Learning Objectives : By the end of the symposium, participants should be able to: * Apply the results from important clinical trials and evidence-based medicine to guide the management of patients with atherosclerosis and structural heart disease * Incorporate new interventional technologies and procedures into the care of patients with complex coronary and endovascular disease * Integrate advances in diagnostic evaluation and therapeutics into the treatment of patients with carotid and peripheral arterial disease * Implement appropriate pharmacologic management in the care of patients undergoing diagnostic arteriography and interventional therapies before, during, and after catheterization * Identify new interventional technologies and propose appropriate applications for patients with cardiovascular disease

Vascular Interventional Advances Annual Conference (VIVA) is organized by Vascular Interventional Advances (VIVA) and would be held during Nov 11 - 15, 2017 at Wynn Las Vegas, Las Vegas, Nevada, United States of America. TARGET AUDIENCE : The target audience for this CME activity is physicians who specialize in, among other areas, interventional cardiology, interventional radiology, vascular medicine, vascular surgery, cardiothoracic surgery, neurosurgery, podiatry and neuroradiology, as well as fellows, and allied health professionals (including nurses, vascular clinic staff, endovascular operating room staff, catheterization laboratory and angiography suite staff, nurse practitioners, vascular technologists, and physicians assistants). LEARNING OBJECTIVES : At the conclusion of the course, the targeted learners should be able: * Understand the current indications, risks, complications, and outcome of medical, interventional, and surgical therapies for the treatment of peripheral arterial and venous diseases. * Incorporate advanced medical, endovascular, and surgical techniques and approaches into their own practices to improve the care and outcomes of patients. * Implement high quality guidelines based programs to improve the early identification and care of patients with non- cardiac vascular conditions. * Increase knowledge in critical decision-making and the comprehensive spectrum of care for patients with stroke and intracranial and extracranial carotid artery disease. * Improve the delivery of balanced and scientifically valid vascular care in accordance with expert opinion and practice. * Utilize strategies learned from the meeting including endovascular technologies, open surgical techniques, and hybrid approaches, for the treatment of patients with aortic diseases. * To gain and employ decision making and procedural strategies and techniques in patients with aortic and visceral aneurysms, dissections, deep venous thrombosis, venous insuff

Dual-graft (DG) adult living donor liver transplantation (ALDLT) with ABO-incompatible (ABOi) and ABO-compatible (ABOc) graft combination is associated with high rates of graft survival, with no significant difference for ABOi and ABOc grafts, according to research published online July 31 in the American Journal of Transplantation. Jae Hyun Kwon, M.D., from the University of Ulsan College of Medicine in Seoul, South Korea, and colleagues conducted a retrospective review of medical records of patients who underwent ABOi DG ALDLT between 2008 and 2014. The authors also assessed the graft regeneration rate using computed tomography volumetric analysis. During a mean follow-up of 57.0 ± 22.4 months, the researchers found that the one-, three-, and five-year patient survival rate was 96.4 percent. The rate of graft survival at one-, three-, and five-years was 96.4, 94.2, and 92.0 percent, respectively; ABOc and ABOi grafts did not differ significantly (P = 0.145). No significant differences were seen between ABOc and ABOi grafts in the biliary complication rate (P = 0.195). There was no significant difference in regeneration rates for ABOi and ABOc grafts. "DG ALDLT with ABOi and ABOc graft combination seems to be a feasible option for expanding the donor pool without additional donor risks," the authors write.

Alzheimer disease (AD) is a chronic neuro-degenerative disease accounting for almost 70% of dementia cases. The most common symptom being short term memory loss, the disease leads to a decline in self management and behavior with impacts varying per individual. Though, AD is an age related disorder with people above 60 being most likely to be affected, individuals with a history of frequent head injuries, depression, hypertension may also carry a risk. Researchers and scientists are unsure about the cause of Alzheimers but studies have been conducted and they claim that 7 out of 10 cases are genetically caused (e4 allele of gene apolipoprotein E). Additionally, pathophysiological causes (Plaques and neurofibrillary tangles, neuronal death) cannot be ruled out in the disease pathology and progression. AD forms one of the most actively explored and researched areas in the field of medicine.

Diabetes Intensive Training is organized by Mayo clinic and would be held during Jul 10 - Sep 29, 2017. The target audience for this medical event basically for Endocrinology, Metabolism and Diabetes, The CME conference has been approved with maximum of 32.00 AMA PRA Category 1 Credit. he Diabetes Intensive Training online course is a comprehensive web based graduate credit level professional enhancement course geared toward practicing professionals. Diabetes Intensive Training is an online self-paced 12 week course through Blackboard Learn. The course is offered on a quarterly basis. The curriculum includes a pretest, 16 modules for study, a post-test requiring an 80% passing score for continuing education credit, and a required evaluation of the course at completion. Currently the curriculum is offered to physicians, physician assistants, advanced nurse practitioners, registered nurses and pharmacists with a current license without restrictions. Target audience: This course is designed for Primary care providers - Family Medicine and General Internal Medicine MDs, Pharmacists, Dietitians, NPs, RNs and APRNs. Learning objectives: Upon conclusion of this program, participants should be able to: * Integrate the principles of theory and research of nursing and medicine into comprehensive health care plan for patients with diabetes including prevention, promotion and treatment * Demonstrate knowledge of evidence based and clinical guidelines in treatment of diabetes inpatient and outpatient management. * Develop and acquire skills for self- directed lifelong learning and staying current in diabetes management (prevention, promotion and treatment).

Conjugated linoleic acid (CLA) supplementation is associated with an increase in serum C-reactive protein (CRP) concentration, according to a review and meta-analysis published online May 29 in Cardiovascular Therapeutics. Mohsen Mazidi, Ph.D., from the Chinese Academy of Sciences in Beijing, and colleagues conducted a systematic review and meta-analysis to examine the impact of CLA supplementation on serum CRP. Data were included from 14 studies. The researchers found that following supplementation with CLAs there was a significant increase in serum CRP concentrations (weighted mean difference, 0.63 mg/dL; 95 percent confidence interval, 0.13 to 1.13; heterogeneity P = 0.026); these findings were robust in sensitivity analyses. The changes in serum CRP levels were found to be independent of CLA supplementation dosage (slope, −0.02; 95 percent confidence interval, −0.10 to 0.12; P = 0.889) or follow-up duration (slope, 0.271; 95 percent confidence interval, −0.05 to 0.59; P = 0.098). "This meta-analysis suggests that CLA supplementation is associated with an increase in plasma CRP concentrations and a reduction in serum adiponectin concentrations, which indicates that CLA supplements have a pro-inflammatory effect," the authors write.

Your enthusiasm for your product is contagious. When you talk about your product, people start to grasp the value immediately, but it's not possible to sit down with every possible user and walk them through it. Product demo video is also a great sales tool. It shows potential customers what they can do with your product or service without needing to travel and give a live demonstration. Best Animation Studios is an animation company/explainer video company with a global presence from the USA, UK, Canada, Australia, Japan, and India. Visit for more: Best Animation Studios

Best Animation Studios is a top 2D animation studio with an experienced team of designers, animators, visual artists, script and content writers, video producers, and several others congregated together for setting up a one-stop destination for envisioning your idea. Our creation team contains over 30 brilliant experts with more than 10 years of animation experience. Best Animation Studios is an animation company/explainer video company with a global presence from the USA, UK, Australia, Japan, and India. Visit for more: Best Animation Studios

Fast and Reliable Ambulance Service in Mahanagar, Lucknow with MedCab MedCab offers the fastest medical transportation services in Mahanagar. For meeting urgent patient needs and transportation to any hospital in Lucknow, MedCab is the most trusted ambulance service. With our 24/7 availability, MedCab can be reached easily for urgent ambulance services in Mahanagar. Mahanagar is one of the prime localities of Lucknow and a well-planned residential area. It is a fast-growing residential neighbourhood with connectivity to other areas in Lucknow, such as Nishatgani, Sanjay Gandhi Puram, Rahim Nagar, Gomti Nagar, Hazratganj and Aishbagh. The Naya Hanuman Temple is in close proximity to Mahanagar. Another excellent attraction close to Mahanagar is the Bara Imambara at a distance of 5 km. The Gomti Riverfront Park is also located within close proximity of Mahanagar. The area is an excellent residential hub with shopping areas developed for the residents, such as the Umrao Mall and Gol Market in Mahanagar. In case of an emergency in any of these areas of Mahanagar, MedCab is a reliable ambulance service for medical assistance and transport. MedCab offers transportation from Mahanagar to a number of nearby hospitals, such as the Aastha Old Age Hospital, Bhaurao Devras Civil Hospital, Midland Healthcare & Research Center, etc. MedCab ambulances can also take the patient to any other hospital within Lucknow as well as to other cities within India.

VR Meetup at the Informatics Labs "HCI" of Hamburg University, 23.06.2016 (in 360° 4K for Cardboard VR). "Cheat your brain" with Prof. Dr. Frank Steinicke & other speakers in German. Shot with "Gear 360" by Dr. Can Ansay, CEO of www.VirtualVizor.com: the best VR-glasses for any smartphone - ideal for 360° videos. Let us film your event in 360° too!

As an emergency medicine physician, you provide initial care for patients with acute illnesses or injuries. Your medical expertise is wide-ranging, so that you are able to quickly diagnose and begin interventions for a variety of conditions. Just as time cannot be wasted when you are with patients, and we do not feel your valuable time should be wasted while searching for required continuing medical education (CME). Our comprehensive database allows you to quickly and easily search, register and even book travel plans for emergency medicine conferences all in one place. Are you looking for CME regarding wilderness medicine? Emergency airway management? Infectious disease control? Palliative medicine ? Find the emergency medicine CME you need by searching our list of events, hosted by leaders in medicine such as Harvard Medical School . Are you ready to attend your next emergency medical conference? Review our list of upcoming conventions, annual updates, courses and more. And for additional events specific to common sub-specialties, check out our database of Critical Care Medicine ,Sports Medicine and Toxicology conferences .

American College of Emergency Physicians (ACEP) Scientific Assembly is organized by American College of Emergency Physicians (ACEP) and would be held during Oct 29 - Nov 01, 2017 at Walter E. Washington Convention Center, Washington, Dist of Col, United States of America. The target audience for this medical event for Emergency Physicians, Emergency Nurses, Nurse Practitioners, Residents and Fellows, Medical Students. This cme conference has been approved with a maximum of 29 AMA PRA Category 1 Credits. This Course will consist of clinical, as well as essential management and risk management tools to aid in your day-to-day practice. With educational courses, skills labs and workshops - ACEP17 is the best source for your emergency medicine education needs! Conference Objectives are : * Abdominal Disorders * Airway, Anesthesia, Analgesia * Cardiovascular * Career Advancement Through Teaching * Critical Care * Critical ED Management * Dematologic Disorders * Emergency Imaging * Head & Neck Disorders * Health Policy * Hematologic Disorders * Infectious Disease * Knowledge Translation * Maintenance of Certification * Metabolic and Endocrine Disorders * Neurology * New Technology * Orthopedics and Sports Medicine * Pediatric Disorders * Prehospital / Disaster Medicine * Professional Skills * Pulmonary Disorders * Risk Management / ED and Law * Toxicology / Environmental * Trauma * Urologic and OB/GYN ACEP17 is the must attend event for anyone engaged in the practice of emergency medicine, including : * Emergency Physicians * Nurse Practitioners * Residents * Medical Students * Physician Assistant * Emergency Department Medical Directors * Hospital Administrators * EMTs/Paramedics

40th Annual San Antonio Breast Cancer Symposium (SABCS) is organized by UT Health Science Center San Antonio and would be held during Dec 5 - 9, 2017 at Henry B. Gonzalez Convention Center, San Antonio, Texas, United States of America. This cme conference has been approved with a maximum of 38.50 AMA PRA Category 1 Credits. The target audience for this medical event for academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as other appropriate health care professionals. Symposium Objective : This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers. The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer.

Best Animation Studios is an animation company/explainer video company with a global presence from the USA, UK, Australia, Japan, and India. Animated explainer video cost is low to moderate, depending on whether you make it with standardized free tools or hire professionals for presenting a top-standard, fashionable explainer video to your audience. Get your superb explainer video from BEST ANIMATION STUDIOS today! We are a reputable animated explainer video company delivering maximum value to clients. Learn more Visit: Best Animation Studios

Best Animation Studios is an animation company/explainer video company with a global presence from the USA, UK, Australia, Japan, and India. We are a 2D Animation company that offers educational videos (E-learning, Animated Stories, Storytelling Videos, Training Videos, Instructional Videos) that let your audience perceive amazing visual instructions that will help them understand a particular product or to imbibe a learning concept. Visit our site: Best Animation Studios

High-Quality Animation Video Production. Scriptwriting | Storyboard | Web Series | 2DAnimation | Educational Videos | Medical Animation | Corporate Videos. Video Marketing Solutions. Fine Quality Best Service. Best creative minds. Best Animation Studios is an animation company/explainer video company with a global presence from the USA, UK, Australia, Japan, and India. Visit for more: Best Animation Studios